Searching for Solutions

Not boring science. Smart + creative. #choosepsychpharmacy #pharmd #psychpharm #AAPP

Psych pharmacists stand up for the unseen. That’s powerful. #choosepsychpharmacy #pharmd #psychpharm #AAPP

The AAPP Foundation continues to proudly support the AAPP Outcomes Initiative with a second $250,000 research grant. This 2025 grant has been awarded to study the impact of care by psychiatric pharmacists on the treatment of depression. The project, “Alternate Prescriber Type - Depression Management (Trial APT-DM): Impact of Psychiatric Pharmacist on Major Depressive Disorder in Primary Care,” will be led by Co-Principal Investigators, Dr. Nathaniel Rickles (UConn School of Pharmacy), Dr.

Efforts to reduce barriers to methadone initiation via partnerships between mobile health programs, SSPs, and OTPs can be a tool in combating the overdose crisis.

In this cohort study, based on data from US healthcare claims databases, initiating citalopram, escitalopram, fluoxetine, or paroxetine while on hydrocodone was associated with an increased risk of opioid overdose compared with sertraline.

Given the high level of stigma and shame experienced by PWUDs, the lowest barrier HRVM access models should be adopted to promote equitable access to harm reduction and basic needs supplies.

Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care without compromising methadone retention and treatment quality.

Medication adherence may prevent overdose, ED use, and hospitalization. Strategies to increase treatment duration/adherence likely avert harm.

Total morbidity-related productivity losses attributable to substance use disorder in the U.S. are substantial, amounting to $92.65 billion in 2023.

Kelly Gable, professor and director of well-being and resilience at Southern Illinois University Edwardsville School of Pharmacy, and member of the AAPP Board, discusses her own cancer journey and how pharmacists need to be more involved and proactive in patients' mental health.

Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications.

New analysis from a WHO global expert committee on vaccine safety has found that, based on available evidence, no causal link exists between vaccines and autism spectrum disorders (ASD). The conclusion reaffirms WHO’s position that childhood vaccines do not cause autism.

No summary available

Despite strong evidence, there is a large implementation gap in both high-income and LMIC settings.

The analysis directly compared the effectiveness of different strategies on the rate of relapse either with or without psychological support.

Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications. Clear guidance from clinicians is essential to support safe, evidence-based decision-making.

This study used our peer-reviewed model of the US opioid crisis to demonstrate how a falling at-risk population combined with probable plateauing of the mortality rate produced the recent decline in US overdose deaths.

ED-initiated XR-BUP was associated with substantial reductions in opioid and polysubstance use during the first week post-discharge, supporting its role in early overdose risk mitigation and highlighting its value as an ED-based intervention for opioid use disorder.

In this cohort study including children prenatally exposed to SSRIs, additional exposure to SSRIs through breastfeeding was not associated with reduced IQ scores.

No summary available

No summary available

Antipsychotic prescriptions for older adults in the U.S. have increased in the last decade, especially from long-term care pharmacies. That’s according to a study published in JAMA Psychiatry, which found that among adults aged 65 and older, rates of antipsychotic use increased from 2.67 per 100 people in 2015 to 4.05 per 100 in 2024. Researchers analyzed a decade of antipsychotic prescription claims from around the country for more than 8 million people aged 65 or older.